BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6175158)

  • 1. Specificity of antibody-dependent lymphocyte cytotoxicity against cerebral tissue constituents in multiple sclerosis. Studies with basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E; Stickl H
    Acta Neurol Scand; 1982 Jan; 65(1):30-7. PubMed ID: 6175158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis.
    Frick E
    J Neurol Sci; 1982; 57(1):55-66. PubMed ID: 6185643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E
    Eur Neurol; 1988; 28(3):120-5. PubMed ID: 2454817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological studies of the pathogenesis of multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides.
    Frick E
    Acta Neurol Scand; 1989 Jan; 79(1):1-11. PubMed ID: 2467501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent lymphocyte cytotoxicity against basic protein of myelin in multiple sclerosis.
    Frick E; Stickl H
    J Neurol Sci; 1980 May; 46(2):187-97. PubMed ID: 6155446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic neuritis and multiple sclerosis. An immunological study.
    Frick E; Stickl H
    Eur Neurol; 1980; 19(3):185-91. PubMed ID: 6156072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of active E-rosette forming lymphocytes from multiple sclerosis patients by gangliosides and cerebrosides.
    Offner H; Konat G
    J Neurol Sci; 1980 Apr; 46(1):101-4. PubMed ID: 6246211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis.
    Møller-Larsen A; Haahr S; Hansen HJ
    J Neuroimmunol; 1987 Jan; 13(3):273-82. PubMed ID: 2432085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis.
    Ilyas AA; Davison AN
    J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic multiple sclerosis research].
    Frick E
    Wien Med Wochenschr; 1985 Jan; 135(1-2):8-9. PubMed ID: 2579511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
    Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
    J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG reactivity against citrullinated myelin basic protein in multiple sclerosis.
    de Seze J; Dubucquoi S; Lefranc D; Virecoulon F; Nuez I; Dutoit V; Vermersch P; Prin L
    J Neuroimmunol; 2001 Jul; 117(1-2):149-55. PubMed ID: 11431015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis.
    Martino G; Olsson T; Fredrikson S; Hojeberg B; Kostulas V; Grimaldi LM; Link H
    Eur J Immunol; 1991 Dec; 21(12):2971-6. PubMed ID: 1721023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis.
    Członkowska A; Półtorak M; Cendrowski W; Korlak J
    Acta Neurol Scand; 1982 Jul; 66(1):121-9. PubMed ID: 6180592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of multiple sclerosis. Antibody dependent cytotoxicity of lymphocytes against myelin basic proteins in multiple sclerosis].
    Frick E; Stickl H
    Fortschr Med; 1977 Oct; 95(37):2235-41. PubMed ID: 914178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
    Warren KG; Catz I
    J Neuroimmunol; 1993 Mar; 43(1-2):87-96. PubMed ID: 7681451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis.
    Zhou SR; Maier CC; Mitchell GW; LaGanke CC; Blalock JE; Whitaker JN
    Neurology; 1998 Feb; 50(2):411-7. PubMed ID: 9484364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte stimulation by gangliosides, cerebrosides and basic protein in juvenile rheumatoid arthritis.
    Offner H; Pedersen FK; Konat G
    J Clin Lab Immunol; 1981 Jul; 6(1):35-7. PubMed ID: 6973634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune lysis of lipid vesicles containing myelin basic protein or glycolipid antigens by multiple sclerosis and normal sera.
    Boggs JM; Samji N; Adamo SA
    J Neurol Sci; 1984; 66(2-3):339-48. PubMed ID: 6085112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.